EGFR and exanthem: A papulopustular (also called acneiform) skin rash is a common toxicity observed with both EGFR-targeting mAb and tyrosine kinase inhibitors (TKI), with a reported incidence of up to 80% in patients treated with EGFR-targeting agents [5], [6], [7].